Eduardo Vilar-Gomez, MD, PhD; Leon A. Adams, MBBS, PhD
Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M16-1303.
Requests for Single Reprints: Eduardo Vilar-Gomez, MD, PhD, Unit for the Clinical Management of Digestive Diseases, Virgen Macarena-Virgen del Rocio University Hospitals, Institute of Biomedicine, Ciberehd, University of Seville, Manuel Siurot Avenue, s/n, Seville, Spain; e-mail, eduardovilar2000@yahoo.com.
Current Author Addresses: Dr. Vilar-Gomez: Unit for the Clinical Management of Digestive Diseases, Virgen Macarena-Virgen del Rocio University Hospitals, Institute of Biomedicine, Ciberehd, University of Seville, Manuel Siurot Avenue, s/n, Seville, Spain.
Dr. Adams: School of Medicine and Pharmacology, University of Western Australia, M50, Nedlands, Western Australia 6009, Australia.
Vilar-Gomez E, Adams LA. Pioglitazone: An Addition to Our Toolbox for Patients With Diabetes and Nonalcoholic Steatohepatitis?. Ann Intern Med. ;165:373–374. doi: 10.7326/M16-1303
Download citation file:
© 2019
Published: Ann Intern Med. 2016;165(5):373-374.
DOI: 10.7326/M16-1303
Published at www.annals.org on 21 June 2016
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism, Gastroenterology/Hepatology.
Results provided by: